Characterization and antigenicity of the promising vaccine candidatePlasmodium vivax34kDa rhoptry antigen (Pv34)

This study describes the identification of thePlasmodium vivaxrhoptry antigen Pv34 whose sequence was obtained based on homology comparison with thePlasmodium falciparumPf34. Thepv34gene product was characterized by molecular biology and immunological techniques. Additionally, association of Pv34 to...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2009-12, Vol.28 (2), p.415
Main Authors: Mongui, Alvaro, Angel, Diana I, Gallego, Gina, Reyes, Claudia, Martinez, Paola, Guhl, Felipe, Patarroyo, Manuel A
Format: Article
Language:English
Subjects:
Bioinformatics
Blood
Candidates
Cytokines
Erythrocytes
Genomes
Genomics
Immunogenicity
Lymphocytes
Malaria
Molecular biology
Molecular weight
Parasites
Parasitic diseases
Peptides
Proteins
Software
Vaccines
Vector-borne diseases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 2
container_start_page 415
container_title Vaccine
container_volume 28
creator Mongui, Alvaro
Angel, Diana I
Gallego, Gina
Reyes, Claudia
Martinez, Paola
Guhl, Felipe
Patarroyo, Manuel A
description This study describes the identification of thePlasmodium vivaxrhoptry antigen Pv34 whose sequence was obtained based on homology comparison with thePlasmodium falciparumPf34. Thepv34gene product was characterized by molecular biology and immunological techniques. Additionally, association of Pv34 to detergent-resistant microdomains (DRMs), expression in late blood-stage parasites and recognition of recombinant Pv34 (rPv34) by sera fromP. vivax-infectedAotusmonkeys and patients was assessed. Lymphoproliferation and cytokine secretion was also evaluated in individuals living in malaria endemic areas. Altogether, the data support carrying out further studies to assess the immunogenicity and protection-inducing ability of rPv34 as component of a multi-antigenic, multi-stage vaccine against vivax malaria.
doi_str_mv 10.1016/j.vaccine.2009.10.034
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1618927993</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3477017681</sourcerecordid><originalsourceid>FETCH-proquest_journals_16189279933</originalsourceid><addsrcrecordid>eNqNjTFPwzAUhC0EEoHyE5AsscCQ9Dl203guIMYODGzVk-M2LzR2sJ2I8uvJUHaG00l3n-4YuxdQCBDVsismNIacLUoAPWcFSHXBMlGvZV6uRH3JMigrlSsBH9fsJsYOAFZS6IwNmxYDmmQD_WAi7zi6Zlaig3VkKJ243_PUWj4E31Mkd-DnN25mlBpMdnvE2PuGxp5PNOG3VJ_PyEPrhxROf2P8cTtJ9bRgV3s8Rnt39lv28PryvnnL5_2v0ca06_wY3FztRCVqXa61lvJ_1C_-wVPo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1618927993</pqid></control><display><type>article</type><title>Characterization and antigenicity of the promising vaccine candidatePlasmodium vivax34kDa rhoptry antigen (Pv34)</title><source>ScienceDirect Journals</source><creator>Mongui, Alvaro ; Angel, Diana I ; Gallego, Gina ; Reyes, Claudia ; Martinez, Paola ; Guhl, Felipe ; Patarroyo, Manuel A</creator><creatorcontrib>Mongui, Alvaro ; Angel, Diana I ; Gallego, Gina ; Reyes, Claudia ; Martinez, Paola ; Guhl, Felipe ; Patarroyo, Manuel A</creatorcontrib><description>This study describes the identification of thePlasmodium vivaxrhoptry antigen Pv34 whose sequence was obtained based on homology comparison with thePlasmodium falciparumPf34. Thepv34gene product was characterized by molecular biology and immunological techniques. Additionally, association of Pv34 to detergent-resistant microdomains (DRMs), expression in late blood-stage parasites and recognition of recombinant Pv34 (rPv34) by sera fromP. vivax-infectedAotusmonkeys and patients was assessed. Lymphoproliferation and cytokine secretion was also evaluated in individuals living in malaria endemic areas. Altogether, the data support carrying out further studies to assess the immunogenicity and protection-inducing ability of rPv34 as component of a multi-antigenic, multi-stage vaccine against vivax malaria.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2009.10.034</identifier><language>eng</language><publisher>Kidlington: Elsevier Limited</publisher><subject>Bioinformatics ; Blood ; Candidates ; Cytokines ; Erythrocytes ; Genomes ; Genomics ; Immunogenicity ; Lymphocytes ; Malaria ; Molecular biology ; Molecular weight ; Parasites ; Parasitic diseases ; Peptides ; Proteins ; Software ; Vaccines ; Vector-borne diseases</subject><ispartof>Vaccine, 2009-12, Vol.28 (2), p.415</ispartof><rights>Copyright Elsevier Limited Dec 11, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Mongui, Alvaro</creatorcontrib><creatorcontrib>Angel, Diana I</creatorcontrib><creatorcontrib>Gallego, Gina</creatorcontrib><creatorcontrib>Reyes, Claudia</creatorcontrib><creatorcontrib>Martinez, Paola</creatorcontrib><creatorcontrib>Guhl, Felipe</creatorcontrib><creatorcontrib>Patarroyo, Manuel A</creatorcontrib><title>Characterization and antigenicity of the promising vaccine candidatePlasmodium vivax34kDa rhoptry antigen (Pv34)</title><title>Vaccine</title><description>This study describes the identification of thePlasmodium vivaxrhoptry antigen Pv34 whose sequence was obtained based on homology comparison with thePlasmodium falciparumPf34. Thepv34gene product was characterized by molecular biology and immunological techniques. Additionally, association of Pv34 to detergent-resistant microdomains (DRMs), expression in late blood-stage parasites and recognition of recombinant Pv34 (rPv34) by sera fromP. vivax-infectedAotusmonkeys and patients was assessed. Lymphoproliferation and cytokine secretion was also evaluated in individuals living in malaria endemic areas. Altogether, the data support carrying out further studies to assess the immunogenicity and protection-inducing ability of rPv34 as component of a multi-antigenic, multi-stage vaccine against vivax malaria.</description><subject>Bioinformatics</subject><subject>Blood</subject><subject>Candidates</subject><subject>Cytokines</subject><subject>Erythrocytes</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Immunogenicity</subject><subject>Lymphocytes</subject><subject>Malaria</subject><subject>Molecular biology</subject><subject>Molecular weight</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>Peptides</subject><subject>Proteins</subject><subject>Software</subject><subject>Vaccines</subject><subject>Vector-borne diseases</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqNjTFPwzAUhC0EEoHyE5AsscCQ9Dl203guIMYODGzVk-M2LzR2sJ2I8uvJUHaG00l3n-4YuxdQCBDVsismNIacLUoAPWcFSHXBMlGvZV6uRH3JMigrlSsBH9fsJsYOAFZS6IwNmxYDmmQD_WAi7zi6Zlaig3VkKJ243_PUWj4E31Mkd-DnN25mlBpMdnvE2PuGxp5PNOG3VJ_PyEPrhxROf2P8cTtJ9bRgV3s8Rnt39lv28PryvnnL5_2v0ca06_wY3FztRCVqXa61lvJ_1C_-wVPo</recordid><startdate>20091211</startdate><enddate>20091211</enddate><creator>Mongui, Alvaro</creator><creator>Angel, Diana I</creator><creator>Gallego, Gina</creator><creator>Reyes, Claudia</creator><creator>Martinez, Paola</creator><creator>Guhl, Felipe</creator><creator>Patarroyo, Manuel A</creator><general>Elsevier Limited</general><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20091211</creationdate><title>Characterization and antigenicity of the promising vaccine candidatePlasmodium vivax34kDa rhoptry antigen (Pv34)</title><author>Mongui, Alvaro ; Angel, Diana I ; Gallego, Gina ; Reyes, Claudia ; Martinez, Paola ; Guhl, Felipe ; Patarroyo, Manuel A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_16189279933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Bioinformatics</topic><topic>Blood</topic><topic>Candidates</topic><topic>Cytokines</topic><topic>Erythrocytes</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Immunogenicity</topic><topic>Lymphocytes</topic><topic>Malaria</topic><topic>Molecular biology</topic><topic>Molecular weight</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>Peptides</topic><topic>Proteins</topic><topic>Software</topic><topic>Vaccines</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mongui, Alvaro</creatorcontrib><creatorcontrib>Angel, Diana I</creatorcontrib><creatorcontrib>Gallego, Gina</creatorcontrib><creatorcontrib>Reyes, Claudia</creatorcontrib><creatorcontrib>Martinez, Paola</creatorcontrib><creatorcontrib>Guhl, Felipe</creatorcontrib><creatorcontrib>Patarroyo, Manuel A</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mongui, Alvaro</au><au>Angel, Diana I</au><au>Gallego, Gina</au><au>Reyes, Claudia</au><au>Martinez, Paola</au><au>Guhl, Felipe</au><au>Patarroyo, Manuel A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization and antigenicity of the promising vaccine candidatePlasmodium vivax34kDa rhoptry antigen (Pv34)</atitle><jtitle>Vaccine</jtitle><date>2009-12-11</date><risdate>2009</risdate><volume>28</volume><issue>2</issue><spage>415</spage><pages>415-</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>This study describes the identification of thePlasmodium vivaxrhoptry antigen Pv34 whose sequence was obtained based on homology comparison with thePlasmodium falciparumPf34. Thepv34gene product was characterized by molecular biology and immunological techniques. Additionally, association of Pv34 to detergent-resistant microdomains (DRMs), expression in late blood-stage parasites and recognition of recombinant Pv34 (rPv34) by sera fromP. vivax-infectedAotusmonkeys and patients was assessed. Lymphoproliferation and cytokine secretion was also evaluated in individuals living in malaria endemic areas. Altogether, the data support carrying out further studies to assess the immunogenicity and protection-inducing ability of rPv34 as component of a multi-antigenic, multi-stage vaccine against vivax malaria.</abstract><cop>Kidlington</cop><pub>Elsevier Limited</pub><doi>10.1016/j.vaccine.2009.10.034</doi></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2009-12, Vol.28 (2), p.415
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_journals_1618927993
source ScienceDirect Journals
subjects Bioinformatics
Blood
Candidates
Cytokines
Erythrocytes
Genomes
Genomics
Immunogenicity
Lymphocytes
Malaria
Molecular biology
Molecular weight
Parasites
Parasitic diseases
Peptides
Proteins
Software
Vaccines
Vector-borne diseases
title Characterization and antigenicity of the promising vaccine candidatePlasmodium vivax34kDa rhoptry antigen (Pv34)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T21%3A06%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20and%20antigenicity%20of%20the%20promising%20vaccine%20candidatePlasmodium%20vivax34kDa%20rhoptry%20antigen%20(Pv34)&rft.jtitle=Vaccine&rft.au=Mongui,%20Alvaro&rft.date=2009-12-11&rft.volume=28&rft.issue=2&rft.spage=415&rft.pages=415-&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2009.10.034&rft_dat=%3Cproquest%3E3477017681%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_16189279933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1618927993&rft_id=info:pmid/&rfr_iscdi=true